  See all
 |
Articles: Myeloproliferative Dz |
Prior Articles
Immunomodulation of Multiple Myeloma Bone Disease
Clinical Reviews in Bone and Mineral Metabolism, 09/25/09
5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - systematic review and meta-analysis
Haematologica, 09/25/09 Molecular characterization of chronic myeloproliferative neoplasias in Mexico
Hematology, 09/24/09 Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndrome
Hematology, 09/24/09 Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
Journal of Clinical Oncology, 09/23/09 Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma
Annals of Hematology, 09/23/09 Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
Bone Marrow Transplantation, 09/23/09 Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case—control study
The Lancet Oncology - Online First, 09/23/09 Reversal of multidrug resistance by curcumin through FA/BRCA pathway in multiple myeloma cell line MOLP-2/R
Annals of Hematology, 09/23/09 JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN)
Leukemia Research, 09/23/09 The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation
International Journal of Cancer, 09/23/09 Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience
Leukemia Research, 09/22/09 Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms
Experimental Hematology, 09/22/09 OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus
Leukemia Research, 09/22/09 Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk
Leukemia Research, 09/22/09 Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma
British Journal of Haematology, 09/21/09 PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL
Oncogene, 09/21/09 Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma
Leukemia and Lymphoma, 09/18/09 Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism
Cancer Research, 09/18/09 Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome
Leukemia and Lymphoma, 09/18/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
187 Available Pages
|
|
